GENERAL
Cipla Bets On Innovation, Biosimilars And AI To Drive Next Phase Of Growth
Cipla Ltd, the Mumbai-headquartered global pharmaceutical major, is stepping up investments in innovation, artificial intelligence, biosimilars and strategic acquisitions as it looks to strengthen its position across key global markets and build a future-ready organisation. India will remain a key growth driver, with the company focusing on therapy areas including respiratory, cardiology, diabetology, urology, oncology, […]
CW Bureau
·
Jun 2, 2026
GENERAL
After 90 Years Of ‘Caring For Life’, Cipla Charts Innovative Journey Path
Ninety years ago, Mumbai headquartered Cipla Ltd, began with a mission to make medicines affordable and accessible for Indians. What started as a commitment to self-reliance in pharmaceuticals has evolved into a global healthcare enterprise serving millions of patients across markets. As Cipla celebrates 90 years of its journey, the company is looking ahead with […]
CW Bureau
·
Jun 2, 2026
HOSPITALITY
Cipla To Invest $100-Mn In Cipla (EU); To Merge Inzpera Healthsciences
Leading global pharmaceutical company Cipla Ltd approved an investment of $100 million in its wholly owned subsidiary Cipla (EU) and amalgamation of Inzpera Healthsciences Ltd with itself. In a regulatory filing, Cipla said that the investment of $100 million in Cipla (EU) will be utilised for onward financial assistance to InvaGen Pharmaceuticals Inc. towards capital […]
CW Bureau
·
Mar 20, 2026
